IP Verse

Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer - EP3725810

PATENT ANALYSIS

Patent Details

Grant Date
Jul 6, 2022
Company
ASTELLAS PHARMA INC.
Oppositions

BAYER INTELLECTUAL PROPERTY GMBH / BAYER AKTIENGESELLSCHAFT

MAIWALD GMBH

More patents of Astellas Pharma Inc.

EP3318259

EP3725810

EP3725778

Want to monitor this patent?

Feel free to send us a message here and we will get back to you